Business ❯Healthcare ❯Pharmaceuticals ❯Consumer Health

Sanofi

French Government Secures Stake in Doliprane Maker Amid US Takeover

Sanofi's Sale of Doliprane to US Fund Sparks Sovereignty Concerns